Possible scenario
Commercial Scale-Up
42% Chance
The most likely path is that Altman's confirmation becomes a clearer commercial endorsement for Cerebras as an OpenAI compute supplier. Investors treat the relationship as validation of Cerebras' wafer-scale architecture, but still wait for contract size, delivery timing and margin terms.
Secondary impacts
- Technology +0.5%
Tickers
- CBRS+5.6%
- AMD-0.4%
- NVDA-0.3%
Portfolio impact
S&P 500+0.2%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.